ARCHIVES

RFAs For Extramural Construction, Mouse Facility Available

This article is from The Cancer Letter archive.

Vol. 16 No. 09 | March 2, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976